Quotes BIOSTAXPAR

Stocks

BTAX

US45252A3059

Market Closed - OTC Markets 09:30:19 2026-08-07 EDT			5-day change	1st Jan Change
0.000100 ^USD	0.00%		0.00%	-

03-27	Callan Jmb Inc. Supports U.S. Scale-Up of Multi-Indication Immune Platform with Phase 2B/3 Advancement in A Collaboration Led by Difgen Pharmaceuticals, Aveva Drug Delivery Systems, Biostax Corp and Sgp Holdings	CI
03-25	DifGen Pharmaceuticals and Aveva Drug Delivery Systems Form Strategic Platform Collaboration with Biostax Corp D/B/A Attune Biotech, SGP Holdings, and Callan JMB	CI

Stock exchange

OTC Markets BTAX 0.000100 $ 0.00% 0.48 $

Markets		Price	Change	Volumes
OTC Markets	BTAX	0.000100USD	0.00%	0.48 $

Quotes 5-day view: BIOSTAXPAR

Delayed Quote OTC Markets

BIOSTAXPAR(BTAX) : Historical Chart (5-day)

	2026-08-07	2026-08-14
Last	US$0.000100	US$0.000000
Volume	4,791	20
Change	-	-100.00%
Opening	US$0.000100	US$0.000000
High	US$0.000100	US$0.000000
Low	US$0.000100	US$0.000000

Performance

1 year	-50.00%
3 years	-99.97%
5 years	-100.00%
10 years	-100.00%

Volumes

markets

Daily volume

4,791

Estimated daily volume

4,791

Avg. Volume 20 sessions

1,204

Daily volume ratio

3.98

Avg. Volume 20 sessions USD

0.12

Record volume 1

380,013

Record volume 2

289,645

Record volume 3

220,913

Capital turnover ratio

Basic data

Market Cap (USD)

10,764

Net sales ()

Number of employees

Sales / Employee (USD)

Indicators

Moving average 100 days

0.0001

Price spread / (MMA100)

0.00%

RSI 9 days

46.22

RSI 14 days

47.52

Historical Quotes: BIOSTAXPAR

Date	Opening	High	Low	Close	Volume	Change

Chart

Duration

Period

More charts

Course Extremes

1 month	0		0
Current year	0		0
1 year	0		0
3 years	0		0.33
5 years	0		5.35
10 years	0		132

Monthly variations

Annual variations

2026	0.00%
2025	-99.41%
2024	-76.72%
2023	-87.83%
2022	-79.93%
2021	-79.39%
2020	+123.23%
2019	+44.44%
2018	-78.37%
2017	-58.40%
2016	-77.26%
2015	+29.35%
2014	-86.82%
2013	-83.92%
2012	+57.25%